Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligodendroglioma, Adult”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT05536986
What this trial is testing

Correlation Between Psychological Stress and Progression of Newly Oligodendroglioma Towards Secondary Glioma

Who this might be right for
Oligodendroglioma, Adult
Henan Provincial People's Hospital 60
Not applicableStudy completedNCT00463008
What this trial is testing

Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium 12
Early research (Phase 1)Study completedNCT00509431
What this trial is testing

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT00002639
What this trial is testing

Suramin in Treating Patients With Recurrent Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Emory University
Early research (Phase 1)Study completedNCT00612001
What this trial is testing

Vaccine Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 8
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Testing effectiveness (Phase 2)Study completedNCT00004688
What this trial is testing

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligodendrogliomaMixed Gliomas+2 more
Emory University 35
Testing effectiveness (Phase 2)Study completedNCT00004147
What this trial is testing

COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Testing effectiveness (Phase 2)WithdrawnNCT00005083
What this trial is testing

Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00498979
What this trial is testing

Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers

Who this might be right for
Stage IV Melanoma
Case Comprehensive Cancer Center 22
Testing effectiveness (Phase 2)Looking for participantsNCT06161974
What this trial is testing

Study of Olutasidenib and Temozolomide in HGG

Who this might be right for
High Grade GliomaAstrocytomaAstrocytoma, Grade III+16 more
Rigel Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT00058123
What this trial is testing

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 55
Not applicableStudy completedNCT00005082
What this trial is testing

Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 1
Early research (Phase 1)Study completedNCT00003876
What this trial is testing

Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Barrett Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00352521
What this trial is testing

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 20
Very early researchStudy completedNCT01165632
What this trial is testing

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+13 more
Mayo Clinic 24
Early research (Phase 1)Study completedNCT00004041
What this trial is testing

Gene Therapy in Treating Patients With Recurrent Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT00069940
What this trial is testing

Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Stromal TumorSarcoma
Dana-Farber Cancer Institute
Early research (Phase 1)Study completedNCT00003484
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Darell D. Bigner, MD, PhD 21
Testing effectiveness (Phase 2)Ended earlyNCT01478321
What this trial is testing

Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+2 more
Northwestern University 54
Next Page